| 1 |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) [J]. Rev Esp Cardiol (Engl Ed), 2022, 75(6): 524.
|
| 2 |
Bohula EA, Katz JN, van Diepen S, et al. Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: the Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness [J]. JAMA Cardiol, 2019, 4(9): 928-935.
|
| 3 |
Bernard S, Deferm S, Bertrand PB. Acute valvular emergencies [J]. Eur Heart J Acute Cardiovasc Care, 2022, 11(8): 653-665.
|
| 4 |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines [J]. Circulation, 2021, 143(5): e35-e71.
|
| 5 |
Cahill TJ, Prothero A, Wilson J, et al. Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation [J]. Heart, 2021, 107(12): 1003-1009.
|
| 6 |
Santangelo G, Bursi F, Faggiano A, et al. The global burden of valvular heart disease: from clinical epidemiology to management [J]. J Clin Med, 2023, 12(6): 2178.
|
| 7 |
Coffey S, Roberts-Thomson R, Brown A, et al. Global epidemiology of valvular heart disease [J]. Nat Rev Cardiol, 2021, 18(12): 853-864.
|
| 8 |
Coffey S, Harper AR, Cairns BJ, et al. Clinical information has low sensitivity for postmortem diagnosis of heart valve disease [J]. Heart, 2017, 103(13): 1031-1035.
|
| 9 |
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [J]. Circulation, 2022, 145(18): e895-e1032.
|
| 10 |
Hamirani YS, Dietl CA, Voyles W, et al. Acute aortic regurgitation [J]. Circulation, 2012, 126(9): 1121-1126.
|
| 11 |
Prêtre R, Chilcott M. Blunt trauma to the heart and great vessels [J]. N Engl J Med, 1997, 336(9): 626-632.
|
| 12 |
Chiappini B, Schepens M, Tan E, et al. Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients [J]. Eur Heart J, 2005, 26(2): 180-186.
|
| 13 |
Habib G, Erba PA, Iung B, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study [J]. Eur Heart J, 2019, 40(39): 3222-3232.
|
| 14 |
Chehab O, Roberts-Thomson R, Ng Yin Ling C, et al. Secondary mitral regurgitation: pathophysiology, proportionality and prognosis [J]. Heart, 2020, 106(10): 716-723.
|
| 15 |
Boudoulas KD, Triposkiadis F, Koenig S, et al. Acute mitral regurgitation with and without acute heart failure [J]. Heart Fail Rev, 2023, 28(5): 1201-1209.
|
| 16 |
Watanabe N. Acute mitral regurgitation [J]. Heart, 2019, 105(9): 671-677.
|
| 17 |
Sannino A, Grayburn PA. Ischemic mitral regurgitation after acute myocardial infarction in the percutaneous coronary intervention era [J]. Circ Cardiovasc Imaging, 2016, 9(8): e005323.
|
| 18 |
Redfield MM, Nicholson WJ, Edwards WD, et al. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations [J]. Ann Intern Med, 1992, 117(1): 50-52.
|
| 19 |
Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine [J]. N Engl J Med, 1997, 337(9): 581-588.
|
| 20 |
Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part Ⅲ [J]. Clin Cardiol. 1995 Apr;18(4): 225-30.
|
| 21 |
Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) [J]. Am J Cardiol, 1999, 83(6): 897-902.
|
| 22 |
Kostyunin AE, Yuzhalin AE, Rezvova MA, et al. Degeneration of bioprosthetic heart valves: update 2020 [J]. J Am Heart Assoc, 2020, 9(19): e018506.
|
| 23 |
Stout KK, Verrier ED. Acute valvular regurgitation [J]. Circulation, 2009, 119(25): 3232-3241.
|
| 24 |
王小亭, 刘大为, 于凯江, 等. 中国重症超声专家共识 [J]. 中华内科杂志, 2016, 55(11): 900-912.
|
| 25 |
Otto CM, Prendergast B. Aortic-valve stenosis--from patients at risk to severe valve obstruction [J]. N Engl J Med, 2014, 371(8): 744-756.
|
| 26 |
Dahou A, Levin D, Reisman M, et al. Anatomy and physiology of the tricuspid valve [J]. JACC Cardiovasc Imaging, 2019, 12(3): 458-468.
|
| 27 |
Sadeghpour A, Hassanzadeh M, Kyavar M, et al. Impact of severe tricuspid regurgitation on long term survival [J]. Res Cardiovasc Med, 2013, 2(3): 121-126.
|
| 28 |
Nath SS, Parashar S. Perioperative management of patients with prosthetic heart valves-a narrative review [J]. Ann Card Anaesth, 2022, 25(3): 254-263.
|
| 29 |
Van den Brink RB. Evaluation of prosthetic heart valves by transesophageal echocardiography: problems, pitfalls, and timing of echocardiography [J]. Semin Cardiothorac Vasc Anesth, 2006, 10(1): 89-100.
|
| 30 |
Masha L, Vemulapalli S, Manandhar P, et al. Demographics, procedural characteristics, and clinical outcomes when cardiogenic shock precedes TAVR in the United States [J]. JACC Cardiovasc Interv, 2020, 13(11): 1314-1325.
|
| 31 |
Kilic A, Sultan I, Chu D, et al. Mitral valve surgery for papillary muscle rupture: outcomes in 1342 patients from the Society of Thoracic Surgeons Database [J]. Ann Thorac Surg, 2020, 110(6): 1975-1981.
|
| 32 |
Estévez-Loureiro R, Shuvy M, Taramasso M, et al. Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: effect of cardiogenic shock on outcomes (IREMMI Registry) [J]. Catheter Cardiovasc Interv, 2021, 97(6): 1259-1267.
|
| 33 |
Giustino G, Camaj A, Kapadia SR, et al. Hospitalizations and mortality in patients with secondary mitral regurgitation and heart failure: the COAPT trial [J]. J Am Coll Cardiol, 2022, 80(20): 1857-1868.
|
| 34 |
Messika-Zeitoun D, Baumgartner H, Burwash IG, et al. Unmet needs in valvular heart disease [J]. Eur Heart J, 2023, 44(21): 1862-1873.
|
| 35 |
De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock [J]. N Engl J Med, 2010, 362(9): 779-789.
|
| 36 |
van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association [J]. Circulation, 2017, 136(16): e232-e268.
|
| 37 |
Thiele RH, Nemergut EC, Lynch C 3rd. The clinical implications of isolated alpha(1) adrenergic stimulation [J]. Anesth Analg, 2011, 113(2): 297-304.
|
| 38 |
Khot UN, Novaro GM, Popović ZB, et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis [J]. N Engl J Med, 2003, 348(18): 1756-1763.
|
| 39 |
Kalra A, Uberoi AS, Latib A, et al. Emerging transcatheter options for tricuspid regurgitation [J]. Methodist Debakey Cardiovasc J, 2017, 13(3): 120-125.
|
| 40 |
Clark JD, Baden HP, Berkman ER, et al. Ethical considerations in ever-expanding utilization of ECLS: a research agenda [J]. Front Pediatr, 2022, 10: 896232.
|
| 41 |
Sang S, Beute T, Heiser J, et al. Early outcomes for valve-in-valve transcatheter aortic valve replacement in degenerative freestyle bioprostheses [J]. Semin Thorac Cardiovasc Surg, 2018, 30(3): 262-268.
|